 SAN DIEGO, Calif., June 10, 2021 PRNewswire -- Viking Therapeutics, Inc. Viking NASDAQ: VKTX, a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate in two upcoming investor conferences. 